15 posts tagged university spinouts from Commercializing Science.
University patent priority decisions are usually made by administrators, not commercialization strategists, and the timing guarantees bad outcomes. Here's what to fix.
A. KovacsReach-through royalty provisions look like smart IP protection but routinely kill university-industry deals. Here's what to do instead.
A. KovacsMost invention valuation methods in tech transfer generate figures that satisfy spreadsheets but fail negotiations. Here's what actually works.
A. KovacsMost license milestone structures protect universities from inaction but accidentally punish real development progress. Here's what to do instead.
A. KovacsMost university patent prosecution focuses on legal coverage, not commercial timing. Here's why that mismatch quietly kills licensing deals before they start.
A. KovacsMTAs look like administrative paperwork, but buried clauses routinely strip universities and startups of the IP rights they need to commercialize research.
A. KovacsVague IP assignment language in sponsored research agreements creates ownership disputes that kill commercialization deals years after the science is done.
A. KovacsExclusive licenses feel like wins for everyone at signing. Here's why they quietly kill commercialization, and what to structure instead.
A. KovacsOption agreements should de-risk early licensing deals, but most TTOs use them wrong. Here's what's broken and how to fix it.
A. KovacsInvention disclosure forms are often the first step in tech transfer, and one of the most damaging. Here's what needs to change.
A. KovacsTRL scores feel objective but are routinely gamed or misread. Here's what's really happening and how to use them honestly.
A. KovacsProof-of-concept funding is the missing bridge between lab discovery and licensable technology, here's why most institutions underinvest in it.
A. KovacsMost university licensing deals collapse not because of bad science or bad intent, but because of preventable negotiation failures. Here's what actually goes wrong.
A. KovacsCorporate VCs systematically lose out on promising university spinouts due to misaligned incentives and poor deal sourcing strategies.
A. Kovacs